Cytokine Regulation of Bone Remodeling Dynamics

Bone remodelling is a dynamic balance between the resorptive activity of osteoclasts and the formative function of osteoblasts. Cytokines, small secreted proteins that mediate cell–cell communication, are central regulators in this process. They influence precursor recruitment, lineage commitment and cellular maturation by activating signalling pathways such as JAK–STAT and NF-κB. Pro-resorptive factors—such as RANKL and interleukins including IL-1, IL-6 and IL-11—promote osteoclast differentiation and activation, while anti-resorptive or osteoanabolic cytokines—such as OPG, IL-10 and oncostatin M—can inhibit osteoclast formation or enhance osteoblast function. Dysregulation of cytokine networks underlies conditions ranging from osteoporosis to inflammatory bone loss. Recent mechanistic insights have elucidated how cytokine gradients, receptor availability and signal transducers coalesce to fine-tune bone turnover rates in health and disease, offering new avenues for therapeutic intervention.

Research from Nature Portfolio

Recent studies have revealed that cytokine signalling and local growth factors jointly dictate osteoclastogenesis thresholds. In particular, IL-6 in combination with its soluble receptor modulates RANKL-induced differentiation of osteoclast precursors through dual regulation of NF-κB, ERK and JNK phosphorylation. This work demonstrates that at low RANKL concentrations, IL-6/sIL-6R potentiates osteoclast formation, whereas at high RANKL levels it suppresses differentiation, thereby acting as a rheostat within the bone microenvironment. These findings underscore the context-dependent nature of cytokine action and suggest that targeting IL-6 trans-signalling could selectively influence bone resorption.

Cytokine Regulation of Bone Remodeling Dynamics publication trend

The graph below shows the total number of articles in cytokine regulation of bone remodeling dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokine: A secreted protein that modulates immune and non-immune cell functions through receptor-mediated signalling.

Osteoclastogenesis: The differentiation process by which precursor cells become bone-resorbing osteoclasts.

RANKL: Receptor activator of nuclear factor κB ligand, a key osteoclastogenic cytokine produced by osteoblasts and stromal cells.

JAK–STAT pathway: A signalling cascade activated by cytokine receptors that controls gene transcription in the nucleus.

gp130: A common signal-transducing subunit shared by the IL-6 cytokine family receptors.

References

1. The Emerging Role of Interleukin-(IL)-11/IL-11R in Bone Metabolism and Homeostasis: From Cytokine to Osteokine. Aging and Disease (2023).
2. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems. Current Osteoporosis Reports (2024).
3. The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology. Experimental & Molecular Medicine (2020).
4. Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways. Scientific Reports (2017).